Join the Idiopathic Pulmonary Fibrosis group to help and get support from people like you.
Idiopathic Pulmonary Fibrosis News
Related terms: IPF
One in Five Idiopathic Pulmonary Fibrosis Deaths May Be Due to Occupational Exposures
FRIDAY, March 7, 2025 – Roughly one in five (21 percent) of idiopathic pulmonary fibrosis (IPF) deaths might be related to occupational exposures, according to research published in the March 6...
FDA Approves Ofev (nintedanib) for Idiopathic Pulmonary Fibrosis
October 15, 2014 – The U.S. Food and Drug Administration today approved Ofev (nintedanib) for the treatment of idiopathic pulmonary fibrosis (IPF). Idiopathic pulmonary fibrosis is a condition in...
FDA Approves Esbriet (pirfenidone) for Idiopathic Pulmonary Fibrosis
October 15, 2014 – The U.S. Food and Drug Administration today approved Esbriet (pirfenidone) for the treatment of idiopathic pulmonary fibrosis (IPF). Idiopathic pulmonary fibrosis is a condition...